MOH — authorised 20 July 2023
- Marketing authorisation holder: DAIICHI SANKYO INC
- Status: likely_approved
🇮🇱 Vanflyta in Israel
MOH authorised Vanflyta on 20 July 2023
Marketing authorisation
Vanflyta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Vanflyta approved in Israel?
Yes. MOH authorised it on 20 July 2023.
Who is the marketing authorisation holder for Vanflyta in Israel?
DAIICHI SANKYO INC holds the Israeli marketing authorisation.